Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Forman

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|October 23, 2018
Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled StudyK Chris Min, Marissa F Dockendorf, John Palcza, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 4, 2010
TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97Gillian P Ritson, Sara K Custer, Brian D Freibaum, et al.
Archives of Neurology|November 14, 2007
Distinct antemortem profiles in patients with pathologically defined frontotemporal dementiaMurray Grossman, David J Libon, Mark S Forman, et al.
American Journal of Medical Genetics. Part A|February 9, 2008
Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementiaVirginia E Kimonis, Sarju G Mehta, Erin C Fulchiero, et al.
Annals of Neurology|May 24, 2006
Frontotemporal dementia: clinicopathological correlationsMark S Forman, Jennifer Farmer, Julene K Johnson, et al.
Journal of Neuropathology and Experimental Neurology|June 20, 2006
Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutationsMark S Forman, Ian R Mackenzie, Nigel J Cairns, et al.
Archives of Neurology|March 17, 2004
17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusionsKirk C Wilhelmsen, Mark S Forman, Howard J Rosen, et al.
Neurobiology of Disease|December 19, 2006
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcriptsAmanda J Myers, Alan M Pittman, Alice S Zhao, et al.
Scientific Reports|June 4, 2016
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to ManAnthony L Gotter, Mark S Forman, Charles M Harrell, et al.
Annals of Neurology|May 1, 2007
Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutationsIan R A Mackenzie, Eileen H Bigio, Paul G Ince, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|October 23, 2018
Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled StudyK Chris Min, Marissa F Dockendorf, John Palcza, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 4, 2010
TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97Gillian P Ritson, Sara K Custer, Brian D Freibaum, et al.
Archives of Neurology|November 14, 2007
Distinct antemortem profiles in patients with pathologically defined frontotemporal dementiaMurray Grossman, David J Libon, Mark S Forman, et al.
American Journal of Medical Genetics. Part A|February 9, 2008
Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementiaVirginia E Kimonis, Sarju G Mehta, Erin C Fulchiero, et al.
Annals of Neurology|May 24, 2006
Frontotemporal dementia: clinicopathological correlationsMark S Forman, Jennifer Farmer, Julene K Johnson, et al.
Journal of Neuropathology and Experimental Neurology|June 20, 2006
Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutationsMark S Forman, Ian R Mackenzie, Nigel J Cairns, et al.
Archives of Neurology|March 17, 2004
17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusionsKirk C Wilhelmsen, Mark S Forman, Howard J Rosen, et al.
Neurobiology of Disease|December 19, 2006
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcriptsAmanda J Myers, Alan M Pittman, Alice S Zhao, et al.
Scientific Reports|June 4, 2016
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to ManAnthony L Gotter, Mark S Forman, Charles M Harrell, et al.
Annals of Neurology|May 1, 2007
Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutationsIan R A Mackenzie, Eileen H Bigio, Paul G Ince, et al.
Pageof 5